Coronavirus 2019

Clinical Trials

WHO launches global megatrial of the four most promising coronavirus treatments

China trials of chloroquine phosphate

WHO Clinical Trial Design Guidelines

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Multiple Endpoints in Clinical Trials: FDA guidance

WHO Therapeutic Working Group

Virus Biology

Genomic Study Points to Natural Origin of COVID-19

The proximal origin of SARS-CoV-2

Coronavirus envelope protein: current knowledge

Inside the coronavirus genome

Ongoing Trials

Trials of hydroxycholoquine in the US, as of April 19, 2020, 76 trials have been registered and ongoing.

Trials of hydroxychloroquine in China, as of March 24, 2020, 27 trials have been registered, 6 were cancelled due to lacking patients.